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Abstract
Studies reporting on the population structure of Staphylococcus aureus in South Africa have focused only on methicillin-resistant S. aureus
(MRSA). This study describes the population structure of S. aureus, including methicillin-susceptible S. aureus (MSSA) isolated from patients
at Tygerberg Academic Hospital, Western Cape province. Pulsed-ﬁeld gel electrophoresis (PFGE), detection of Panton–Valentine leukocidin
(PVL), spa typing, multilocus sequence typing (MLST), agr typing and SCCmec typing were used to characterize strains. Of 367
non-repetitive S. aureus isolates collected over a period of 1 year, 56 (15.3%) were MRSA. Skin and soft tissue infections were the most
frequent source (54.8%), followed by bone and joint (15.3%) and respiratory tract infections (7.7%). For strain typing, PFGE was the most
discriminative method, and resulted in 31 pulsotypes (n = 345, 94.0%), as compared with 16 spa clonal complexes (CCs) (n = 344, 93.4%).
Four MLST CCs were identiﬁed after eBURST of sequence types (STs) of selected isolates. One hundred and sixty isolates (MSSA, n = 155,
42.2%) were PVL-positive, and agr types I–IV and SCCmec types I–V were identiﬁed. Our S. aureus population consisted of genotypically
diverse strains, with PVL being a common characteristic of MSSA. MSSA and MRSA isolates clustered in different clones. However, the
dominant MRSA clone (ST612) also contained an MSSA isolate, and had a unique genotype. Common global epidemic MRSA clones, such as
ST239-MRSA-III and ST36-MRSA-II, were identiﬁed. A local clone, ST612-MRSA-IV, was found to be the dominant MRSA clone.
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Introduction
Staphylococcus aureus is a facultative intracellular bacterium that
is considered to be one of the most important and signiﬁcant
human pathogens. Methicillin-resistant S. aureus (MRSA)
emerged as a major clinical and epidemiological hospital-asso-
ciated problem in the 1980s [1], even though Jevons described
the ﬁrst MRSA isolate in the 1960s [2]. SCCmec was ﬁrst
described as a novel mobile genomic element, capable of
site-speciﬁc and orientation-speciﬁc integration into and
precise excision from any S. aureus strain [3].
Typing techniques are required for the effective discrimi-
nation and characterization of isolates in order to establish
clonal relatedness and clonal dominance. Numerous molecular
techniques have been described for S. aureus typing, of which
macrorestriction analysis (MRA) with pulsed-ﬁeld gel electro-
phoresis (PFGE) is still regarded as the reference standard, as
it is still the most discriminatory technique available for
S. aureus [4].
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Information regarding the molecular epidemiology and
pathogenicity of S. aureus in South Africa is limited. The
Pan-European Antimicrobial Resistance Using Local Surveil-
lance (PEARLS) study indicated methicillin resistance to be
33.3% for South African strains isolated during 2001–2002 [5].
There is also a lack of data regarding community-associated
MRSA (CA-MRSA) in Africa. A study on MRSA isolates
collected nationally revealed the presence of the following
internationally described MRSA clones: sequence type (ST)
5-MRSA-I, ST239-MRSA-III, ST612-MRSA-IV, ST36-MRSA-II,
and ST22-MRSA-IV [6].
A genotypic study conducted at Tygerberg hospital on 113
S. aureus blood culture isolates by spa typing identiﬁed 49
different spa types that grouped into seven clusters [7]. spa
type t037, associated with the Brazilian/Hungarian epidemic
MRSA clone, was identiﬁed as the dominant spa type. ST612
was identiﬁed as a dominant MRSA clone in another study
from Cape Town [8].
The aim of this study was to elucidate the population
structure of S. aureus strains isolated from speciﬁc clinical
sites of infection from patients admitted to Tygerberg
hospital.
Materials and Methods
Study design and setting
This cross-sectional study was undertaken in the molecular
laboratory of the Division of Medical Microbiology of the
Faculty of Medicine and Health Sciences, Stellenbosch Univer-
sity, located at Tygerberg Hospital. This is a 1200-bed
academic hospital in the Western Cape that serves a diverse
population of approximately 2.5 million people, including areas
with high human immunodeﬁciency virus (HIV) and tubercu-
losis prevalence rates. Annually, 60 600 patients are admitted,
and the S. aureus prevalence rate is 3.2%.
Sample collection and patient demographics
Consecutive, non-duplicate, single-patient S. aureus isolates
were collected over a 1-year period (2009–2010). Bacterial
isolates were identiﬁed as S. aureus with the Vitek 2 system
(Vitek 2 GP identiﬁcation cards) (bioMerieux, Marcy l’Etoile,
France), which was also used for antimicrobial susceptibility
testing (Vitek 2 AST-P603 card). The isolates were subcul-
tured on blood agar plates and stored at 80°C. Specimen
type, infection source and methicillin resistance were recorded
where available, as well as patient age, gender, and HIV status
(if available). Isolates were classiﬁed as paediatric (≤12 years)
or adult (≥13 years). The following isolates were obtained
from the American Type Culture Collection (ATCC) (www.
atcc.org) as control isolates: ATCC-BAA-38; ATCC-BAA-39;
ATCC-BAA-42: ATCC-1680; ATCC-BAA-81; ATCC-BAA-83;
ATCC-BAA-88; and ATCC-BAA-1707. Strain NCTC8325-4
was obtained from the Health Protection Agency of the UK
(www.hpa.org.uk).
Genomic DNA extraction
Total genomic DNA was extracted with a previously published
method [9].
Strain typing
PFGE. A previously published protocol using SmaI was used to
type all isolates [10]. The banding patterns were used to
establish isolate relatedness according to the criteria of
Tenover et al. [11]. For PFGE pulsotypes where SmaI restric-
tion digestion was unable to differentiate between the spa
typing and multilocus sequence typing (MLST) clonal complex
(CC) results within a particular PFGE pulsotype, ApaI mac-
rorestriction was applied [12]. PFGE pulsotypes were classiﬁed
on the basis of the number of isolates and unique PFGE types as
major pulsotypes (more than ten isolates/PFGE types), inter-
mediate pulsotypes (four to nine isolates/PFGE types), or minor
pulsotypes (two or three isolates/PFGE types).
spa typing and MLST. spa typing was performed as previously
described [13]. spa types were clustered into spa-CCs with the
algorithm Based Upon Repeat Pattern (BURP) (RIDOM
StaphType v.2.1.1; RIDOM, W€urzburg, Germany) with a
distance cost of ≤5; spa types shorter than four repeats were
excluded [14]. MLST was performed for all PFGE pulsotypes
classiﬁed as major or intermediate, as published previously
[15]. Allelic proﬁles were obtained from the website http://
saureus.mlst.net, and STs were clustered into CCs with
eBURST v.3 (http://saureus.mlst.net/eburst).
SCCmec, agr and lukS/F detection. SCCmec typing was per-
formed as described by Milheirico et al. [16]. The agr type of
each isolate was identiﬁed as described by Lina et al. [17]. The
lukS/F genes were detected according to a previously published
protocol [18].
Statistical analyses
Association between clonality and clinical/bacterial characteris-
tics. Fisher’s exact test was used to determine associations
between clonality and the following clinical/bacterial charac-
teristics: (i) methicillin resistance; (ii) paediatric/adult clones;
(iii) infection source; (iv) gender; and (v) Panton–Valentine
leukocidin (PVL) status. p-Values were corrected for multiple
analyses with the Holm–Bonferroni method. Fisher’s exact
test was also used to investigate the association between
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methicillin resistance and agr type and PVL status. A signiﬁ-
cance level of 0.05 was used.
Discriminatory power of typing techniques. A discriminatory
index with 95% CIs was calculated for PFGE and spa typing
as published previously [19].
Results
Sample collection and methicillin resistance
Three hundred and sixty-seven S. aureus isolates were
collected, of which 56 (15.3%) were MRSA.
Patient demographics and clinical sources of infection
One hundred and six isolates (28.9%) were classiﬁed as
paediatric isolates, and 261 isolates (71.1%) were classiﬁed as
adult isolates. Two hundred and eighteen isolates (59.4%)
were collected from males, 148 isolates (40.3%) from females,
and one (0.3%) from a post-mortem sample of unknown
gender. The median age of patients was 30 years, and ranged
from 3 days to 87 years. Eighty-ﬁve isolates (23.2%) were
collected from persons with known HIV status, of which 21
(24.7%) were from HIV-positive persons, representing 5.7% of
the whole collection. Three hundred and ﬁfty-two isolates
(95.9%) were collected from known clinical sources (Fig. 1).
Typing results
SmaI PFGE. Three hundred and sixty-six isolates (99.7%) were
typeable by SmaI restriction analysis; this resulted in the
generation of 269 unique PFGE types, grouped into 31 PFGE
pulsotypes and 21 singletons at an 80% similarity cut-off. Two
hundred and ﬁfty-four (69.4%) of the typeable isolates grouped
into eight major pulsotypes, 62 (16.9%) grouped into ten
intermediate pulsotypes, and 29 (7.9%) grouped into 13 minor
pulsotypes (Table 1). The pulsotypes identiﬁed were given
customized names to facilitate analyses.
ApaI PFGE. ApaI MRA was performed on the pulsotype
THW-V, as three spa-CCs and three agr variants were
observed. MRA with ApaI clearly showed the presence of
three clusters with an 80% cut-off, which correlated with the
agr typing and spa clustering. A numerical index combined with
the previously assigned alphabetical name from SmaI MRA was
assigned, resulting in THW-V1, THW-V2, and THW-V3.
spa typing. The spa types of 366 isolates (99.7%) were
determined. One hundred and twenty-seven unique spa types
were identiﬁed. Thirty-ﬁve of these spa types were identiﬁed
as novel types. In this study, 78 spa types (21.3%) represented
single isolates. The dominant spa type was t891 (n = 51,
13.9%). With the BURP algorithm, the 127 spa types were
clustered into 16 spa-CCs. The spa types of 14 isolates (3.8%)
were classiﬁed as singletons, and eight spa types from seven
isolates (1.9%) were excluded from the analyses because they
were too short. Spa-CC891 was identiﬁed as the dominant
spa-CC, comprising 64 isolates (17.5%) (Table 1).
SCCmec typing. SCCmec type IV was identiﬁed as the dom-
inant variant, being present in 30 isolates (53.6%). SCCmec
type I was identiﬁed in nine (16.1%) isolates, SCCmec type II
in six (10.7%) isolates, and SCCmec types III and V in ﬁve
(8.9%) isolates each. One isolate was non-typeable and
yielded no ampliﬁcation pattern, except for the mecA internal
control.
agr typing. The agr types of all isolates were determined, and
all four agr types were identiﬁed; agr type I was the dominant
type, being identiﬁed in 199 isolates (54.2%). agr type III was
identiﬁed in 80 isolates (21.8%), agr type II in 68 isolates
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FIG. 1. The distribution of isolates
collected according to source. The
isolates are displayed as collected
according to the clinical source, starting
with the most prevalent source (skin and
soft tissue). The number of isolates
collected from each source is also
indicated.
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(18.5%), and agr type IV in 20 isolates (5.4%). No association
was identiﬁed between methicillin resistance and agr type.
PVL. One hundred and sixty isolates (43.6%) tested positive
for lukS/F, of which 155 (42.2%) were methicillin-susceptible
S. aureus (MSSA) isolates and ﬁve (1.4%) were MRSA isolates.
MRSA isolates were associated with PVL negativity (p 0.0001).
MLST. A representative isolate was randomly selected for
each major and intermediate PFGE pulsotype. Nineteen MLST
STs were identiﬁed from 20 isolates, which clustered into two
MLST CCs and 14 singletons, according to a similarity of six of
seven loci. To group singletons into CCs, eBURST analysis was
performed with all previous STs submitted to the database.
This allowed us to group the STs into four CCs (CC30, CC8,
CC15, and CC5) and seven singletons (ST22, ST121, ST45,
ST6, ST12, ST97, and ST88) (Table 1). In this article, CC8 is
referred to as separate from CC5 for ease of interpretation
and comparison with other research articles, although CC8
has now been incorporated into CC5 (http://saureus.mlst.net/
eburst).
Combined molecular typing data. A good correlation was seen
after combination of the data obtained with the various typing
techniques. All major (n = 9) and intermediate (n = 11) PFGE
pulsotypes each had a unique agr type and spa-CC, and were
predominantly or completely PVL-positive or PVL-negative.
Only four PFGE pulsotypes consisted of both methicillin-sus-
ceptible and methicillin-resistant isolates: THW-C, THW-J,
THW-O, and THW-BB. Each PFGE pulsotype had a unique ST,
except for ST612, which was identiﬁed in both PFGE pulsotype
THW-N and PFGE pulsotype THW-O. Spa-CCs were divided
into numerous clones by both PFGE and MLST. A unique
SCCmec type was present in all MRSA isolates from the same
TABLE 1. Pulsed-ﬁeld gel electrophoresis (PFGE) pulsotypes identiﬁed, with supporting data from other typing techniques
PFGEa
No. of
isolates
Status of
pulsotypes
MLST
spa-CC
SCCmec
(types: number) agr
No.
PVL-positive
(%)ST CCb
THW-A 46 Major 1865 30 21 MSSA III 38 (83)
THW-D 3 Minor – – NF MSSA I 0
THW-E 16 Major 121 121 NF MSSA IV 15 (94)
THW-F 3 Minor – – NF MSSA IV 3 (100)
THW-G 7 Intermediate 1862 8 1597 MSSA I 3 (43)
THW-H 2 Minor – – 64 MSSA I 1 (50)
THW-K 2 Minor – – 64 MSSA I 1 (50)
THW-M 2 Minor – – 64 MSSA I 0
THW-Q 2 Minor – – 267 MSSA III 2 (100)
THW-R 2 Minor – – 84 MSSA II 0
THW-S 16 Major 15 15 84 MSSA II 2 (13)
THW-T 2 Minor – – 84 MSSA II 0
THW-U 2 Minor – – 191/100 MSSA II 1 (50)
THW-V 6 (V3)c Intermediate 12 12 888 MSSA II 1 (17)
14 (V2)c Major 1 15 NF III 5 (36)
18 (V1)c Major 6 6 64 I 1 (6)
2 Minor ND ND NF III 2 (100)
THW-W 5 Intermediate 97 97 267 MSSA I 0
THW-X 5 Intermediate 188 15 189 MSSA I 1 (25)
THW-Y 17 Major 1863 5 2 MSSA II 1 (6)
THW-Z 6 Intermediate 1864 5 2 MSSA II 1 (17)
THW-CC 2 Minor – – 1597 MSSA I 0
THW-DD 2 Minor – – st MSSA I 2 (100)
THW-EE 37 Major 45 45 15 MSSA I 1 (19)
THW-B 6 Intermediate 36 30 21 Type II: 6 III 0
THW-N 8 Intermediate 612 8 64 Type IV: 8 I 0
THW-P 2 Minor – – 64 Type IV: 2 I 0
THW-AA 9 Intermediate 5 5 2 Type I: 9 II 0
THW-L 6 Intermediate 239 8 21 Type III: 5 I 0
NT: 1
THW-C 63 Major 22 22 891 MSSA: 58 I 57 (98)
Type V: 1 1 (100)
Type IV: 4 0
THW-I 3 Minor – – 148 MSSA: 2 I 0
Type V: 1 0
THW-J 6 Intermediate 8 8 64 MSSA: 4 I 1 (25)
Type V: 2 0
THW-O 13 Major 612 8 64 MSSA: 1 I 0
Type IV: 12 1 (8)
THW-BB 4 Intermediate 88 88 186 MSSA: 2 III 1 (50)
Type IV: 2 2 (100)
CC, clonal complex; MLST, multilocus sequence typing; MSSA, methicillin-susceptible Staphylococcus aureus; NF, no founder; ND, not determined; NT, not typeable; st, singleton;
ST, sequence type; +, positive.
aIsolates identiﬁed as singletons (n = 21) and non-typeable (n = 1) are not included in the table.
bCC8 was discussed as an individual CC for ease of interpretation and comparison with previously published literature, although recent data on the MLST website indicate that this
CC is now a part of CC5.
cApaI macrorestriction analysis.
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PFGE pulsotype, except for THW-L where one isolate was
non-typeable, and THW-C, where both SCCmec type IV
(PVL-negative) and SCCmec type V (PVL-positive) were iden-
tiﬁed. A correlation between MLST, spa and agr typing data
was only achieved through ApaI MRA for PFGE pulsotype
THW-V. Regarding PFGE pulsotypes THW-C, THW-J, and
THW-O, it was seen that a corresponding MSSA strain was
present for an MRSA strain with the same spa type, which
might suggest local SCCmec acquisition. PFGE was identiﬁed as
the most discriminatory technique, and PFGE/80% clustering as
the most discriminatory clustering technique (Table 2). See
Table 3 for all statistical associations identiﬁed.
Discussion
A prominent ﬁnding of this study is the high prevalence of
lukS/F identiﬁed in 155 (42.2%) MSSA isolates. This is not in
agreement with other international ﬁndings, which suggest
that the prevalence of PVL is 3–5% [1]. Such a high PVL
prevalence rate has previously been reported in Cambodia/
Thailand [20], where PVL was associated with a better clinical
outcome, as well as in sub-Saharan African countries [21].
Therefore, it appears that there is a signiﬁcant difference in
the PVL prevalence rate between developed and developing
countries.
The PVL prevalence rate among MRSA isolates in this study
was 9%, which was lower than in MSSA isolates. This may
suggest that the PVL-positive MRSA isolates have acquired the
phages encoding this virulence factor before acquiring SCCmec
elements encoding methicillin resistance determinants. In this
study, a large proportion of this S. aureus population consists
of PVL-positive MSSA isolates from STs that are also
associated with MRSA isolates. These isolates could thus
conceivably be a source of new MRSA clones upon the
acquisition of an SCCmec element. It is also worth noting that
all PFGE complexes associated with skin and soft tissue
infections (SSTIs) are also associated with PVL-positive
isolates, which indicates either a strong linkage with crucial
virulence factors for SSTIs or a pathogenetic role of PVL
during the pathogenesis of these infections, as suggested by
Lina et al. [18].
PFGE was an excellent technique for establishing
clonal relatedness and dominance in our setting, and was
also the most discriminatory method (Table 2). We used
the PFGE results together with data generated through
spa, agr and SCCmec typing to elucidate the population
structure of S. aureus. PFGE identiﬁed 34 pulsotypes (nine
TABLE 2. The discriminatory power of the typing tech-
niques used in this study
Method
No. of
strains
included
No. of
types/
groups DI 95% CI
spa typing 366a 127 0.965 0.956–0.974
spa typing/BURP 358b 16 0.890 0.877–0.902
PFGEc 366a 269 0.991 0.988–0.994
PFGE/80% clusteringc 366a 31 0.918 0.905–0.931
DI, discriminatory index; BURP, Based Upon Repeat Pattern; PFGE, pulsed-ﬁeld gel
electrophoresis.
aOne isolate was non-typeable.
bTypes excluded from cluster analyses because they were too short.
cSmaI PFGE.
TABLE 3. Adjusted p-values for testing associations between clonality and the clinical/bacterial characteristics
PFGE
MLST
(ST:CC)
Status of
pulsotype
Bacterial/clinical characteristic
Methicillin
resistance
Paediatric
or adult
Source of
infection Gender PVL
THW-A 1865:30 Major 0.0096 (S) 1 0.0096 (SSTI) 1 0.0096 (+)
THW-B 36:30 Intermediate 0.0096 (R) 0.055 0.35 1 0.0096 ()
THW-C 22:22 Major 0.0096 (S) 1 0.0096 (SSTI) 1 0.0096 (+)
THW-E 121:121 Major 0.0096 (S) 1 0.0096 (SSTI) 1 0.0096 (+)
THW-G 1862:8 Intermediate 0.0096 (S) 0.055 0.35 1 1
THW-J 8:8 Intermediate 0.265 0.055 1 1 0.0096 ()
THW-L 239:8 Intermediate 0.0096 (R) 1 1 1 0.0096 ()
THW-N 612:8 Intermediate 0.0096 (R) 1 1 1 0.0096 ()
THW-O 612:8 Major 0.0096 (R) 1 1 1 0.0096 ()
THW-S 15:15 Major 0.0096 (S) 1 1 1 0.0096 ()
THW-V Various Major 0.0096 (S) 1 1 1 0.0096 ()
THW-W 97:97 Intermediate 0.0096 (S) 1 1 1 0.0096 ()
THW-X 188:15 Intermediate 0.0096 (S) 1 1 1 0.0096 ()
THW-Y 1863:5 Major 0.0096 (S) 1 1 1 0.0096 ()
THW-Z 1864:5 Intermediate 0.0096 (S) 1 1 1 0.0096 ()
THW-AA 5:5 Intermediate 0.0096 (R) 1 1 1 0.0096 ()
THW-BB 88:88 Intermediate 0.26 1 0.35 1 0.0096 (+)
THW-EE 45:45 Major 0.0096 (S) 1 1 1 0.0096 ()
CC, clonal complex; MLST, multilocus sequence typing; PFGE, pulsed-ﬁeld gel electrophoresis; PVL, Panton–Valentine leukocidin; R, resistant; S, sensitive; SSTI, skin and soft tissue;
ST, sequence type; +, positive; , negative.
Signiﬁcant adjusted p-values (<0.05) are indicated in bold.
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major, 11 intermediate, and 14 minor), whereas spa typing
identiﬁed 16 spa-CCs by use of the BURP algorithm. The
nine major and 11 intermediate PFGE pulsotypes yielded 19
MLST STs, which clustered into four CCs and seven
singletons. It is worth noting that three MLST STs (ST1,
ST6, and ST12) were identiﬁed that could not be
discriminated with SmaI MRA. However, these were effec-
tively discriminated with ApaI restriction enzyme. Isolates of
the ST239-MRSA-III-t037 (CC8) background and of the
CC30 background were clustered in a single spa-CC
(CC021). This is because of the integration of a large
chromosomal fragment from ST30 in ST8, leading to the
evolution of ST239 [22]. As in previous studies, PFGE
supplemented with spa typing and MLST could be used
successfully in this study to investigate the population
structure of S. aureus [19].
ST22-THW-C (major) was identiﬁed as the dominant
MSSA clone. The presence of an MRSA isolate indicates that
an SCCmec acquisition event may have occurred not too
long ago, and this MRSA clone could be the ﬁrst of a
CA-MRSA lineage potentially associated with SSTI.
ST22-MRSA-IV is usually associated with the epidemic MRSA
clone EMRSA-15, which was a dominant clone in the UK for
decades [23]. However, in our population it was established
as the dominant MSSA clone, with one MRSA isolate with an
SCCmec V element. The data thus suggest that this lineage
may give rise to a CA-MRSA clone (possibly ST22-MRSA-V).
ST8, ST612, ST239 and ST1862 were all identiﬁed as part of
CC8. Two MRSA STs were identiﬁed. ST612, a double-locus
variant of ST8, was the only ST that was subdivided by PFGE
into two pulsotypes, THW-O (major) and THW-N
(intermediate). One MSSA isolate was present in THW-O
and had the same spa type as an MRSA isolate, t1443. It is
speculated that this could possibly represent the local
acquisition of SCCmec by MSSA isolates, leading to the rise
of a local MRSA clone. As only one MSSA isolate was
identiﬁed, it can be seen that the MSSA strains of this CC
have been largely replaced by their MRSA counterparts. All
members of ST8 carried spa t1476, and two MRSA isolates
were also present, carrying SCCmec type V. These data,
again, support the local acquisition of SCCmec elements, and
these ST8-MRSA-V isolates might be the ﬁrst of a new
CA-MRSA clone. ST15 is known worldwide to be associated
with MSSA isolates. Today, MRSA isolates from ST15 are
scarce [24], although ‘early’ MRSA isolates have been
identiﬁed from this ST [25]. ST1-MRSA-IV is associated
with the USA400 clone [10,24], a CA-MRSA clone that is
prevalent in the USA [10] (Table 3).
ST1863 and ST1864 were identiﬁed as novel MLST STs
during this study, and they are both single-locus variants of
ST5. Two MSSA lineages exist that are closely related to ST5
and are endemic to our setting. It is possible that this ST5
emerged locally after it underwent evolutionary changes after
acquisition of an SCCmec I element.
ST121-MSSA-THW-E (major) is commonly only associated
with an MSSA background, and has previously been reported
[23,26]. This ST is a common, global cause of SSTIs [27].
Although MRSA isolates have been described from this ST,
they are usually rare. Overall, our S. aureus population is
very heterogeneous, especially the MSSA strains, and it is
noted that there is a clear lack of a common genetic
background between MSSA and MRSA strains. This either
suggests that only some MSSA lineages come into contact
with SCCmec elements or other bacterial species that can
act as possible donors, that only some MSSA lineages can
successfully sustain the integration of SCCmec elements in
the genome, or that certain MRSA clones have lost the
SCCmec element.
Two clones were identiﬁed as being associated with
HIV-positive status: ST8-MSSA-THW-K (minor) and
ST612-MRSA-IV-THW-P (minor). Both clones were associ-
ated with MLST CC8, which has been reported previously
[28]. ST8 isolates have also been reported as USA300 isolates,
and have been associated with necrotizing disease in
HIV-positive persons [28]. ST612 has been described as the
dominant ST, although from a different PFGE pulsotype.
Further studies on the association of bacterial clonality with
HIV-positive status are required.
Conclusion
The molecular typing techniques used in combination were
sufﬁcient to elucidate and study the population structure of
S. aureus, allowing us to identify various clones, some of
which were associated with certain clinical categories. The
population studied is composed of a highly diverse population
of endemic MSSA clones and epidemic MRSA clones,
indicating the lack of a common genetic background between
MSSA and MRSA isolates. A prominent ﬁnding is the high PVL
prevalence, especially among MSSA clones. The MSSA
population identiﬁed and studied could act as a potential
reservoir for CA-MRSA clones upon the acquisition of
SCCmec elements, leading to the rise of PVL-positive
CA-MRSA clones. More studies are required to investigate
the signiﬁcant difference in the PVL prevalence rate between
developed and developing countries. Some of the MRSA
clones identiﬁed could potentially have emerged locally
through the acquisition of SCCmec elements, including the
unique, dominant MRSA clone, ST612.
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